Exelixis Inc Retained Earnings
Exelixis Inc (EXEL) had Retained Earnings of -$262.53 million as of 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-07-03: Retained Earnings (Accumulated Deficit) -$262.53M.
- 2026-04-03: Retained Earnings (Accumulated Deficit) -$215.79M.
- 2026-01-02: Retained Earnings (Accumulated Deficit) -$76.83M.
- 2025-10-03: Retained Earnings (Accumulated Deficit) -$106.06M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-07-03 | -$262.53M 10-Q · filed 2026-08-05 | |
| 2026-04-03 | -$215.79M 10-Q · filed 2026-05-05 | |
| 2026-01-02 | -$76.83M 10-Q · filed 2026-08-05 | |
| 2025-10-03 | -$106.06M 10-Q · filed 2025-11-04 | |
| 2025-07-04 | -$219.54M 10-Q · filed 2025-07-28 | |
| 2025-04-04 | -$163.29M 10-Q · filed 2025-05-13 | |
| 2025-01-03 | -$98.65M 10-K · filed 2026-02-10 | |
| 2024-09-27 | -$90.29M 10-Q · filed 2024-10-29 | |
| 2024-06-28 | -$199.97M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | -$258.95M 10-Q · filed 2024-04-30 | |
| 2023-12-29 | -$173.35M 10-K · filed 2025-02-11 | |
| 2023-09-29 | -$126.05M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $11.19M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $5.80M 10-Q · filed 2023-05-09 | |
| 2022-12-30 | -$34.23M 10-K · filed 2024-02-06 | |
| 2022-09-30 | -$4.05M 10-Q · filed 2022-11-01 | |
| 2022-07-01 | -$77.26M 10-Q · filed 2022-08-09 | |
| 2022-04-01 | -$147.93M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$216.51M 10-K · filed 2023-02-07 | |
| 2021-10-01 | -$311.67M 10-Q · filed 2021-11-02 | |
| 2021-07-02 | -$349.88M 10-Q · filed 2021-08-05 | |
| 2021-04-02 | -$445.97M 10-Q · filed 2021-05-06 | |
| 2021-01-01 | -$447.57M 10-K · filed 2022-02-18 | |
| 2020-10-02 | -$475.96M 10-Q · filed 2020-11-05 | |
| 2020-07-03 | -$443.92M 10-Q · filed 2020-08-06 | |
| 2020-04-03 | -$510.74M 10-Q · filed 2020-05-05 | |
| 2020-01-03 | -$559.35M 10-K · filed 2021-02-11 | |
| 2019-09-27 | -$628.09M 10-Q · filed 2019-10-30 | |
| 2019-06-28 | -$725.55M 10-Q · filed 2019-07-31 | |
| 2019-03-29 | -$804.59M 10-Q · filed 2019-05-01 | |
| 2018-12-28 | -$880.36M 10-K · filed 2020-02-25 | |
| 2018-09-28 | -$1.24B 10-Q · filed 2018-11-01 | |
| 2018-06-29 | -$1.37B 10-Q · filed 2018-08-01 | |
| 2018-03-30 | -$1.45B 10-Q · filed 2018-05-02 | |
| 2017-12-30 | -$1.57B 10-K · filed 2019-02-22 | -$1.57B 10-Q · filed 2018-05-02 |
| 2017-12-29 | -$1.83B 10-K · filed 2019-02-22 | |
| 2017-09-30 | -$1.87B 10-Q · filed 2017-11-01 | |
| 2017-06-30 | -$1.95B 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$1.97B 10-Q · filed 2017-05-01 | |
| 2016-12-31 | -$1.98B 10-Q · filed 2017-11-01 | |
| 2016-12-30 | -$1.98B 10-K · filed 2018-02-26 | |
| 2016-09-30 | -$2.02B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | -$2.04B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | -$2.00B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | -$1.91B 10-K · filed 2017-02-27 | -$1.94B 10-K · filed 2016-02-29 |
| 2015-09-30 | -$1.89B 10-Q · filed 2015-11-10 | |
| 2015-06-30 | -$1.85B 10-Q · filed 2015-08-11 | |
| 2015-03-31 | -$1.80B 10-Q · filed 2015-04-30 | |
| 2014-12-31 | -$1.75B 10-K · filed 2017-02-27 | -$1.77B 10-K · filed 2015-03-02 |
| 2014-09-30 | -$1.71B 10-Q · filed 2014-11-04 | |
| 2014-06-30 | -$1.65B 10-Q · filed 2014-07-31 | |
| 2014-03-31 | -$1.57B 10-Q · filed 2014-05-01 | |
| 2013-12-31 | -$1.49B 10-K · filed 2017-02-27 | -$1.50B 10-K · filed 2014-02-20 |
| 2013-09-30 | -$1.43B 10-Q · filed 2013-10-30 | |
| 2013-06-30 | -$1.36B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | -$1.30B 10-Q · filed 2013-05-07 | |
| 2012-12-31 | -$1.25B 10-K · filed 2017-02-27 | -$1.25B 10-K · filed 2013-02-21 |
| 2012-09-30 | -$1.20B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | -$1.17B 10-Q · filed 2012-08-02 | |
| 2012-03-31 | -$1.13B 10-Q · filed 2012-05-03 | |
| 2011-12-31 | -$1.11B 10-K · filed 2013-02-21 | |
| 2011-09-30 | -$1.15B 10-Q · filed 2011-10-27 | |
| 2011-06-30 | -$1.23B 10-Q · filed 2011-08-04 | |
| 2010-12-31 | -$1.18B 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |